Akso Health vs Ucommune International
AHG and UK side by side, both in miscellaneous business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AHG and UK compare
Akso Health grew revenue faster over the last twelve months (−6.4% versus −66.2% for Ucommune International).
Akso Health scores higher on the StockData Score (7 against 5 for Ucommune International), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AHG | UK |
|---|---|---|
| Size and price | ||
| Share price | $1.24 | $1.44 |
| Change, 1 year | −17.9% | −83.4% |
| Change, 5 years | −57.7% | −99.9% |
| Beta (5Y) | 0.53 | 0.57 |
| Employees | 12 | 42 |
| StockData Score | ||
| Total score | 7 (better) | 5 |
| Valuation score | 0 | 0 |
| Growth score | 1 (better) | 0 |
| Performance score | 1 (better) | 0 |
| Health score | 5 | 5 |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | −6.4% (better) | −66.2% |
| Revenue growth, 5Y average | 51.1% (better) | −50.5% |
| EPS growth (TTM) | −93.8% | – |
| Profitability | ||
| Gross margin | −0.08% (better) | −2.9% |
| Operating margin | −150% (better) | −155% |
| Net margin | −135% | – |
| FCF margin | −92.5% | −80.8% (better) |
| Return on equity | −9.8% | – |
| Return on invested capital | −16.1% (better) | −31.9% |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 21.77 (better) | 1.07 |
| Piotroski F-score | 5 | – |
| Ownership | ||
| Held by institutions | 0.01% | – |
| Held by insiders | 0.00% | 0.00% |
Go deeper
- AHG stock overview
- AHG income statement
- AHG valuation and score
- UK stock overview
- UK income statement
- UK valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.